How high is a high risk? Prioritising high-risk individuals in an influenza pandemic.

Vaccine

Institute for Experimental Medicine, Christian-Albrechts-Universität zu Kiel, Arnold-Heller-Str. 3, Haus 28, 24104 Kiel, Germany. Electronic address:

Published: December 2014

Pandemic contingency plans frequently define priority groups that are given preferential access to influenza vaccine. One of the most commonly named groups for prioritisation is that of high-risk individuals. However, current models of categorisation are unsatisfactory in a number of ways. It will be argued that existing vaccination strategies fail to adequately define what kind of risks are being considered and how, as well as on the basis of which information, these risks are calculated. Moreover, it will be suggested that existing vaccination strategies fail to specify of what magnitude a risk has to be, in order to be categorised as 'high'. Finally, it shall be argued that a mere focus on the size of a risk factor may lead policy makers to overlook underlying concerns of distributive justice.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2014.10.020DOI Listing

Publication Analysis

Top Keywords

high-risk individuals
8
existing vaccination
8
vaccination strategies
8
strategies fail
8
high high
4
high risk?
4
risk? prioritising
4
prioritising high-risk
4
individuals influenza
4
influenza pandemic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!